A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status:
Recruiting
Trial end date:
2029-09-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of guselkumab in
participants with moderately to severely active ulcerative colitis (UC).